Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omacor (n-3 polyunsaturated fatty acids) on HAART-induced hypertriglyceridemia in HIV-infected patients
2007-001921-86Phase 4Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- May 2007
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertriglyceridemia and human immunodeficiency virus infection (HIV) comparing Omacor arm with Placebo arm (2 arms). Started May 2007; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemiahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-001921-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001921-86.